Related Experiment Video
Updated: Jun 28, 2025
09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
Immunophenotypic clustering in paediatric acute myeloid leukaemia
Hui Liu1, Kefei Wu1, Wenting Hu1
1Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
British Journal of Haematology
|April 19, 2024
Summary
Immunophenotype profiling identifies a distinct subgroup of pediatric acute myeloid leukemia (AML) with poor prognosis, regardless of traditional markers. This finding aids in tailoring AML treatments.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Acute myeloid leukemia (AML) is a complex cancer with varied subtypes.
- Immunophenotyping via flow cytometry is crucial for AML diagnosis.
- Understanding antigen expression is key to refining AML classification and treatment.
Purpose of the Study:
- To characterize antigen expression in pediatric AML cases.
- To identify immunophenotypic differences across morphological and molecular subgroups.
- To discover immune markers associated with prognosis in pediatric AML.
Main Methods:
- Flow cytometry was used to analyze antigen expression in pediatric AML patients.
- Morphological and molecular genetic subgroups were considered.
- Cox regression analysis was employed to identify prognostic antigens.
Main Results:
- A subgroup of pediatric AML patients with unfavorable prognosis was identified based on immunophenotype.
- This immunophenotypic subgroup was distinct from morphological FAB and genetic aberration classifications.
- Specific antigens were found to significantly influence AML patient prognosis.
- The antigenic profiles of CBFA2T3::GLIS2 and FUS::ERG fusion groups resembled the RAM phenotype.
Conclusions:
- Immunophenotype is a significant factor in predicting prognosis for pediatric AML.
- Immunophenotypic characterization can identify high-risk patients irrespective of other classifications.
- These findings support tailoring treatment strategies for pediatric AML based on immunophenotype.
